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Val M. Runge, MD
T he article “High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evaluation of the macrocyclic gadolinium-based contrast agent gadobutrol” by
Radbruch et al1 provides critical new information regarding gadolinium deposition in the dentate nu-
cleus. The conclusion, from a study of 30 patients, is that no signal intensity increase is seen with gadobutrol.
This is in sharp distinction to a prior publication2 and, as stated in the conclusion of Radbruch et al, “adds
further support to the hypothesis that the molecular structure of a gadolinium based contrast agent (GBCA)
as eithermacrocyclic or linear is the crucial factor for its potential to cause gadoliniumdeposition in the brain.”
History is important, in particular, to avoid the mistakes of the past. Publication and dissemination
of well-performed, scientifically valid research are also crucial. Unfortunately, the scientific literature
contains errors, many accidental, which in most cases are corrected with time. A prominent example
was the belief that peptic ulcers were caused by acid. Indeed, this was part of my instruction, along with
contemporaries across the world, while at Stanford Medical School in the late 1970s. It took years of
dedicated research by Barry Marshall and Robin Warren,3 beginning in 1983, to dispel this belief. Be-
cause of their work, which was awarded a Nobel Prize in 2005, treatment today is simple and effective,
with the enormous costs (both financial and in human terms) of surgery and lifelong medical treatment
so avoided.
Unfortunately, scientific fraud also occurs, although rare. In the radiology literature, the best
known example is that of Dr Robert A. Slutsky at the University of California San Diego in the 1980s.
Of the 137 articles published by Dr Slutsky (over only a 6-year period), it was eventually concluded
that 77 were valid, 48 were questionable, and 12 were fraudulent.4 Yet, despite the attention that this
case received, even articles that were retracted continued to be cited.
Regarding the publication in European Radiology2 that the current results call into question, it is
important to note that the European Radiology study was previously rejected by Investigative Radiology.
A decision on rejection was reached in part due to the only figure provided not showing an increase in
dentate nucleus signal intensity and the absence of a control patient population.
Incorrect conclusions drawn on the basis of clinical studies, regarding specifically the dentate nu-
cleus T1-hyperintensity issue, likely also include 2 studies—published in 2009 and 2011—that attribute
the T1-hyperintensity of the dentate nucleus to secondary progressive multiple sclerosis5 and brain irra-
diation.6 Looking at this issue in retrospect, both patient populations are ones in which a high number of
gadolinium chelate administrations would have been likely, thus arguing that the findings were likely not
related to the disease process but rather to multiple prior gadolinium chelate administrations.
The study of Radbruch et al provides further evidence supporting a significant difference between
macrocyclic and linear chelates in terms of safety profile. As the authors state in their conclusion, for
linear GBCAs—specifically those that have no benefit in terms of improved diagnosis in comparison
to the approvedmacrocyclic GBCAs—their ongoing clinical use should be reassessed. Let us remember,
as physicians, above all to do no harm.
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